ABO and Alzheimer disease: Extensive studies now indicate that Aβo induce a synaptic failure at early stages of AD by exerting their toxic effect as specific ligands for synapses (Colom‐Cadena et al., 2020; Esparza et al., 2013; Koffie et al., 2009).